Abemaciclib plus endocrine therapy significantly improves overall survival in high-risk early breast cancer, reducing death risk by 15.8% compared to endocrine therapy alone.

Dear: I’ve read that the Social Security Administration offers a lump-sum payment to new retirees who need some extra cash. I ...

The trial demonstrated that the HIF-2α inhibitor belzutifan showed meaningful antitumor activity with a 26% objective response rate, a significant achievement particularly for rare and ...

Palazestrant in combination with ribociclib demonstrated encouraging activity across all dose cohorts and subgroups ; Median PFS was 15.5 months in the 120 mg palazestrant cohort ...

Individuals with systolic dysfunction congestive heart failure may have decreased neuronal density, decreased neuronal function (reuptake or retention of norepinephrine), or a combination of these, ...

Neurocrine Biosciences shows strong growth with rising INGREZZA sales, expanding pipeline, and solid financials despite key ...